vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and UNITED STATES LIME & MINERALS INC (USLM). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $87.9M, roughly 1.2× UNITED STATES LIME & MINERALS INC). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 9.8%). UNITED STATES LIME & MINERALS INC produced more free cash flow last quarter ($25.7M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 10.8%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

United States Lime & Minerals Inc is a leading US-based natural resources enterprise that produces high-calcium lime, dolomitic lime, limestone and related mineral products. Its core client segments cover infrastructure construction, steel manufacturing, agricultural soil amendment, environmental emission control and industrial processing, serving customers across North America.

IMCR vs USLM — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.2× larger
IMCR
$104.5M
$87.9M
USLM
Growing faster (revenue YoY)
IMCR
IMCR
+14.5% gap
IMCR
24.3%
9.8%
USLM
More free cash flow
USLM
USLM
$61.2M more FCF
USLM
$25.7M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
10.8%
USLM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
USLM
USLM
Revenue
$104.5M
$87.9M
Net Profit
$30.5M
Gross Margin
97.4%
48.0%
Operating Margin
-18.8%
41.0%
Net Margin
34.7%
Revenue YoY
24.3%
9.8%
Net Profit YoY
13.2%
EPS (diluted)
$-0.61
$1.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
USLM
USLM
Q4 25
$104.5M
$87.9M
Q3 25
$103.7M
$102.0M
Q2 25
$98.0M
$91.5M
Q1 25
$93.9M
$91.3M
Q4 24
$84.1M
$80.1M
Q3 24
$80.2M
$89.4M
Q2 24
$75.4M
$76.5M
Q1 24
$70.5M
$71.7M
Net Profit
IMCR
IMCR
USLM
USLM
Q4 25
$30.5M
Q3 25
$-177.0K
$38.8M
Q2 25
$-10.3M
$30.8M
Q1 25
$5.0M
$34.1M
Q4 24
$27.0M
Q3 24
$8.7M
$33.4M
Q2 24
$-11.6M
$26.1M
Q1 24
$-24.4M
$22.4M
Gross Margin
IMCR
IMCR
USLM
USLM
Q4 25
97.4%
48.0%
Q3 25
99.5%
51.2%
Q2 25
98.9%
45.8%
Q1 25
99.1%
50.6%
Q4 24
99.6%
44.3%
Q3 24
99.4%
48.2%
Q2 24
97.7%
45.5%
Q1 24
99.7%
42.7%
Operating Margin
IMCR
IMCR
USLM
USLM
Q4 25
-18.8%
41.0%
Q3 25
-6.9%
45.3%
Q2 25
-15.2%
39.0%
Q1 25
-3.9%
43.7%
Q4 24
-23.1%
38.8%
Q3 24
-10.6%
42.6%
Q2 24
-21.2%
39.1%
Q1 24
-37.6%
35.9%
Net Margin
IMCR
IMCR
USLM
USLM
Q4 25
34.7%
Q3 25
-0.2%
38.0%
Q2 25
-10.5%
33.7%
Q1 25
5.4%
37.4%
Q4 24
33.7%
Q3 24
10.9%
37.3%
Q2 24
-15.4%
34.0%
Q1 24
-34.7%
31.3%
EPS (diluted)
IMCR
IMCR
USLM
USLM
Q4 25
$-0.61
$1.06
Q3 25
$0.00
$1.35
Q2 25
$-0.20
$1.07
Q1 25
$0.10
$1.19
Q4 24
$-0.47
$-2.20
Q3 24
$0.17
$1.16
Q2 24
$-0.23
$0.91
Q1 24
$-0.49
$3.92

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
USLM
USLM
Cash + ST InvestmentsLiquidity on hand
$864.2M
$371.1M
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$381.0M
$630.8M
Total Assets
$1.1B
$681.0M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
USLM
USLM
Q4 25
$864.2M
$371.1M
Q3 25
$892.4M
$349.5M
Q2 25
$882.8M
$319.9M
Q1 25
$837.0M
$300.6M
Q4 24
$820.4M
$278.0M
Q3 24
$901.3M
$255.0M
Q2 24
$859.6M
$222.5M
Q1 24
$832.8M
$207.0M
Total Debt
IMCR
IMCR
USLM
USLM
Q4 25
$0
Q3 25
$0
Q2 25
$0
Q1 25
$0
Q4 24
$0
Q3 24
$438.7M
$0
Q2 24
$452.5M
$0
Q1 24
$452.5M
$0
Stockholders' Equity
IMCR
IMCR
USLM
USLM
Q4 25
$381.0M
$630.8M
Q3 25
$396.6M
$602.3M
Q2 25
$388.5M
$563.3M
Q1 25
$378.5M
$532.2M
Q4 24
$360.7M
$497.7M
Q3 24
$377.8M
$474.2M
Q2 24
$359.1M
$441.1M
Q1 24
$359.5M
$415.3M
Total Assets
IMCR
IMCR
USLM
USLM
Q4 25
$1.1B
$681.0M
Q3 25
$1.1B
$652.8M
Q2 25
$1.1B
$607.4M
Q1 25
$1.0B
$585.3M
Q4 24
$1.0B
$543.2M
Q3 24
$1.1B
$521.8M
Q2 24
$1.0B
$484.2M
Q1 24
$994.0M
$464.0M
Debt / Equity
IMCR
IMCR
USLM
USLM
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
1.16×
0.00×
Q2 24
1.26×
0.00×
Q1 24
1.26×
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
USLM
USLM
Operating Cash FlowLast quarter
$-32.7M
$45.6M
Free Cash FlowOCF − Capex
$-35.5M
$25.7M
FCF MarginFCF / Revenue
-34.0%
29.2%
Capex IntensityCapex / Revenue
2.8%
22.6%
Cash ConversionOCF / Net Profit
1.49×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$102.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
USLM
USLM
Q4 25
$-32.7M
$45.6M
Q3 25
$-4.5M
$45.9M
Q2 25
$26.0M
$34.0M
Q1 25
$435.0K
$39.4M
Q4 24
$-14.0M
$38.6M
Q3 24
$21.1M
$39.0M
Q2 24
$23.5M
$21.2M
Q1 24
$-4.6M
$27.2M
Free Cash Flow
IMCR
IMCR
USLM
USLM
Q4 25
$-35.5M
$25.7M
Q3 25
$-5.2M
$31.3M
Q2 25
$25.6M
$20.8M
Q1 25
$137.0K
$24.6M
Q4 24
$-17.5M
$27.6M
Q3 24
$20.3M
$33.9M
Q2 24
$23.1M
$16.8M
Q1 24
$-5.0M
$20.3M
FCF Margin
IMCR
IMCR
USLM
USLM
Q4 25
-34.0%
29.2%
Q3 25
-5.0%
30.7%
Q2 25
26.1%
22.7%
Q1 25
0.1%
26.9%
Q4 24
-20.9%
34.4%
Q3 24
25.3%
37.9%
Q2 24
30.7%
21.9%
Q1 24
-7.1%
28.4%
Capex Intensity
IMCR
IMCR
USLM
USLM
Q4 25
2.8%
22.6%
Q3 25
0.7%
14.4%
Q2 25
0.4%
14.5%
Q1 25
0.3%
16.3%
Q4 24
4.3%
13.8%
Q3 24
1.0%
5.8%
Q2 24
0.4%
5.7%
Q1 24
0.6%
9.5%
Cash Conversion
IMCR
IMCR
USLM
USLM
Q4 25
1.49×
Q3 25
1.18×
Q2 25
1.10×
Q1 25
0.09×
1.16×
Q4 24
1.43×
Q3 24
2.42×
1.17×
Q2 24
0.81×
Q1 24
1.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons